Cargando…
The prognostic value of CD44 isoform expression in endometrial cancer.
Isoforms of the transmembrane glycoprotein CD44 have been implicated in tumour cell adhesion, tumour differentiation and metastatic spread in various human malignancies. We investigated the expression of CD44 isoforms containing variant exons v3, v5, v6 and v7-8 in 156 human endometrium cancer speci...
Autores principales: | Tempfer, C., Haeusler, G., Kaider, A., Hefler, L., Hanzal, E., Reinthaller, A., Breitenecker, G., Kainz, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150118/ https://www.ncbi.nlm.nih.gov/pubmed/9569051 |
Ejemplares similares
-
CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
por: Tempfer, C., et al.
Publicado: (1998) -
Serum M3/M21 in ovarian cancer patients.
por: Tempfer, C., et al.
Publicado: (1997) -
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999) -
Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
por: Lösch, A., et al.
Publicado: (1996) -
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial
por: Seebacher, V, et al.
Publicado: (2010)